NEOGAP Therapeutics
Stockholm
About NEOGAP Therapeutics
NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $29.5M
- Last round: Series Unknown (Feb 2026)
- Website: neogap.se
- Phone: +46 733 54 21 94
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/neogap-therapeutics-36631 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.